Request appointment
1665 Aurora CtAurora, CO 80045
Fax+1 720-848-0180
Overview of Dr. Kessler
Dr. Elizabeth Kessler is an oncologist in Aurora, CO and is affiliated with UCHealth University of Colorado Hospital. She received her medical degree from New York Medical College and has been in practice 20 years. She is one of 140 doctors at UCHealth University of Colorado Hospital who specialize in Oncology. She has more than 60 publications and over 500 citings.
Education & Training
University of ColoradoFellowship, Hematology and Medical Oncology, 2010 - 2014- University of ColoradoResidency, Internal Medicine, 2006 - 2009
New York Medical CollegeClass of 2006
Certifications & Licensure
CO State Medical License 2009 - 2027
WY State Medical License 2021 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
Clinical Trials
- Chemotherapy Before Surgery in Treating Patients With High Grade Upper Urinary Tract Cancer Start of enrollment: 2015 Aug 27
- Testosterone Therapy in Castration Resistant Prostate Cancer Start of enrollment: 2019 Jan 18
- Care Planning Framework in Advanced Cancer (ABC123) Start of enrollment: 2022 Feb 15
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- A Phase II Trial Using Grape Seed Extract for Prostate Cancer Patients With Nonmetastatic Prostate-Specific Antigen Progression After Local Therapy.Paul Maroni, Tad A Manalo, Hannah Baker, Elizabeth R Kessler, Andrew Nicklawsky
Molecular Carcinogenesis. 2026-09-27 - A Phase II Study of Berzosertib in Combination with Carboplatin Compared with Docetaxel with Carboplatin in Metastatic Castration-Resistant Prostate Cancer.Atish D Choudhury, Caiwei Zhong, Wanling Xie, Bose S Kochupurakkal, Peter I-Fan Wu
Cancer Research Communications. 2026-09-01 - Pembrolizumab Plus Lenvatinib in Participants with Docetaxel-pretreated Metastatic Castration-resistant Prostate Cancer: Results from KEYNOTE-365 Cohort E.Marinela Augustin, Brigitte Laguerre, Capucine Baldini, Ahmed H Zedan, Enrique Gonzalez-Billalabeitia
European Urology Oncology. 2026-05-02
Press Mentions
Prostate Cancer Patient Hopes His Story Encourages Early Detection for OthersSeptember 1st, 2021
Study Evaluates Geriatric Health During Androgen Deprivation TherapyJuly 12th, 2017
Study Evaluates Overall Geriatric Health During Androgen Deprivation TherapyJune 5th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: